GLP-1s, HRT, and bone health in menopause: what to track
Track weight trend, appetite, GI effects, strength habits, sleep, hot flashes, DXA notes, falls, medication timing, and clinician questions.
GLP-1s, HRT, and bone health in menopause: what to track
Quick answer: If you are using or discussing a GLP-1 medication and HRT during menopause, track weight trend, appetite, GI symptoms, strength habits, protein routine, sleep, hot flashes, night sweats, DXA or bone-density notes, falls or fracture history, medication timing, and the questions you want your clinician to review.
Who this tracker is for
This guide is for perimenopause and menopause women age 40-55 who are already using, considering, or discussing GLP-1 medication and/or HRT with qualified clinicians and are seeing bone-health or body-composition headlines.
It is not a recommendation to combine medications, stop medications, or change prescribed care. Use the tracker to organize context for your own clinician.
Why bone-health tracking needs context
In midlife, bone health can overlap with menopause stage, weight change, activity level, nutrition, medications, family history, falls, and prior test results. A single symptom or scale number does not explain the whole picture.
A useful log separates:
- what changed
- when it changed
- what else was happening at the same time
- what you want reviewed by a clinician
What to track weekly
Use a simple weekly review rather than obsessing over daily fluctuations.
Track:
- weight trend or clothing-fit changes, if you choose to monitor them
- appetite changes and nausea, constipation, diarrhea, reflux, or other GI effects
- strength training, walking, balance work, or other activity
- protein habits or meals that were hard to finish
- sleep quality and morning fatigue
- hot flashes and night sweats
- mood, brain fog, or energy changes that affect daily function
- medication timing notes, refill gaps, or side-effect concerns
Bone-density and safety notes to keep together
If bone health is part of the conversation, keep these notes easy to find:
- DXA or bone-density test date and location
- prior osteopenia, osteoporosis, fracture, or stress-fracture history if previously diagnosed
- falls, near-falls, balance concerns, or new dizziness
- family history you have been asked to document
- calcium, vitamin D, supplement, or medication list to review with your clinician
- questions about strength, nutrition, or monitoring frequency
Questions to bring to a clinician
Consider asking:
- What bone-health information should I track between visits?
- Do my weight, appetite, strength, sleep, or fall notes change what you want to monitor?
- Should any symptoms prompt earlier medical guidance?
- How should I prepare for a DXA or bone-health follow-up?
- What information from my HRT and GLP-1 timeline would be most useful for you?
What not to conclude from tracking
A tracker cannot decide whether HRT, a GLP-1 medication, nutrition changes, or exercise is right for you. It also cannot diagnose bone loss or explain a symptom by itself. It can help you bring a cleaner timeline to a qualified clinician.
FAQ
Should I track weight every day?
Not necessarily. If weight tracking is stressful or not clinically useful for you, use the schedule your clinician recommends or focus on weekly trends and function notes.
Should I include workouts and protein notes?
Yes, if bone health or body composition is part of the conversation. Strength habits, appetite, and nutrition context can make the visit more practical.
Should I track hot flashes and sleep too?
Yes. Menopause symptoms, sleep disruption, and fatigue can affect activity, appetite, mood, and follow-up priorities.
Why Stabilize fits this use case
Stabilize helps organize menopause symptoms, HRT context, medication notes, sleep, body-change observations, refill gaps, and clinician questions into one follow-up-ready timeline.
Medical disclaimer: This content is for informational and tracking purposes only and does not constitute medical advice. Always consult qualified physicians for diagnosis and treatment decisions.